Periodic Reporting for period 1 - NextSkins (Living Therapeutic and Regenerative Materials with Specialised Advanced Layers)
Periodo di rendicontazione: 2022-11-01 al 2023-10-31
We also worked on bimolecular engineering to push the bio-encapsulations strategies further. This has resulted in successful expression of three bacterial enzymes in S. cerevisiae. The expression system was based on the standard YTK kit. For optimising expression we have implemented a high throughput screening method with a yeast display procedure and executed it in an inter-lab setup with the FACS (fluorescent assisted cell sorting) device. Silk proteins have been expressed and we have analysed thin film formation at the air-water interface and tested different methods for film stabilisation for films on a solid support.
In terms of materials fabrication, although only some of the genetically engineered strains are ready, we still grew initial prototypes for the LTS and LRS materials. These materials are not functional yet, but they allow to demonstrate some of the expected material and biological properties.
To assess how potential users would experience the LTS material, we have created the initial mimics for LTS that simulate their potential tactile and responsive characteristics. These prototypes were utilized in user studies involving AD patients to gather preliminary feedback. Subsequently, the prototypes have undergone further development for presentation at the workshop with Advisory Board members, where we discussed the feasibility, desirability, and potential social impact of the application ideas.
To assess the potential applications of the LRS material, we have conducted a literature and practice review on the use of biomineralization in design. This resulted in a taxonomy, which we will use for selecting application ideas in the next phase.